Toprak Omer, Cirit Mustafa
Department of Nephrology, Atatürk Training and Research Hospital, Izmir, Turkey.
Kidney Blood Press Res. 2006;29(2):84-93. doi: 10.1159/000093381. Epub 2006 May 16.
An increasing number of diagnostic imaging and interventional procedures require the use of radiographic contrast agents which has led to a parallel increase in the incidence of contrast-induced nephropathy (CIN). CIN is a serious clinical problem associated with increased morbidity and mortality, particularly in patients with chronic renal failure (see the Case Report). A key step to minimize CIN is to identify patients at risk of CIN. The aim of the present review was to summarize the knowledge about the risk factors of CIN, including the review of ultimate clinical research and developments.
越来越多的诊断性成像和介入性操作需要使用放射造影剂，这导致造影剂肾病（CIN）的发病率相应增加。CIN是一个严重的临床问题，与发病率和死亡率的增加相关，尤其是在慢性肾衰竭患者中（见病例报告）。将CIN风险降至最低的关键一步是识别有CIN风险的患者。本综述的目的是总结关于CIN风险因素的知识，包括对最终临床研究和进展的综述。
